Relaxin-3 The human relaxin peptide family encompasses a group of seven structurally related peptides that play crucial roles across various physiological systems, including reproduction, metabolism, cardiovascular function, and neurological health.Tissue specificity.Expressed predominantly in brain regions. Highest expression in substantia nigra and pituitary, followed by hippocampus, spinal cord, ... These peptides, belonging to the insulin superfamily, are characterized by a conserved structure of two peptide chains linked by disulfide bonds. While commonly associated with pregnancy and reproductive processes, the broad expression and diverse functions of human relaxin peptides highlight their significance beyond these initial associations, making them subjects of ongoing research for therapeutic applications.
The human relaxin peptide family comprises seven distinct members: three relaxin-like (RLN) peptides—RLN1, RLN2, and RLN3—and four insulin-like (INSL) peptides: INSL3, INSL4, INSL5, and INSL6.Everything we know about the human relaxin peptide family These peptides share a common structural fold, similar to insulin, featuring two polypeptide chains, an A-chain and a B-chain, connected by three disulfide bonds. This structural similarity is indicative of their shared evolutionary origins within the insulin superfamily. For instance, Human Relaxin-2 (H2Relaxin) is a well-studied member, a 6 kDa, 53 amino acid polypeptide crucial in female reproduction. Its synthesis, often achieved through methods like solid-phase peptide synthesis, allows for its study and potential therapeutic use.
The functional significance of human relaxin peptides extends far beyond their initial discovery.Tissue specificity.Expressed predominantly in brain regions. Highest expression in substantia nigra and pituitary, followed by hippocampus, spinal cord, ... They are broadly expressed in the body, indicating widespread physiological involvement. Relaxin-2, for example, is produced by the corpus luteum and placenta and is vital during pregnancy for processes such as cervical dilation and mammary gland development. However, relaxin peptides also exhibit roles in male reproduction, and some members, like Relaxin-3, are predominantly expressed in the brain, suggesting roles in neurological functions. Research is actively exploring their potential in managing conditions such as prostate cancer and cardiovascular diseases, underscoring their therapeutic promise.Peptide hormone relaxin: from bench to bedside
The actions of human relaxin peptides are mediated through specific receptors, primarily the relaxin family peptide receptors (RXFPs).作者:NA Patil·2017·被引用次数:95—The human relaxin peptide family consists ofseven cystine‐rich peptides, four of which are known to signal through relaxin family peptide receptors. There are four known RXFP receptors: RXFP1, RXFP2, RXFP3, and RXFP4. These receptors bind to specific relaxin family peptides, initiating intracellular signaling cascades that lead to various physiological responses.Relaxin For instance, RXFP1 is the primary receptor for relaxin-2, while RXFP2 binds to INSL3. Understanding these ligand-receptor interactions is key to developing targeted therapies.2022年9月28日—The human relaxin peptides arebroadly expressed in the body, functioning in reproductive, metabolic, cardiovascular, and neurological health. The precise molecular mechanisms by which these peptides interact with their receptors are areas of active investigation, with studies focusing on ligand recognition and signaling dynamicsIdentification of Potent and Long-Acting Single-Chain Peptide ....
The multifaceted roles of human relaxin peptides have positioned them as promising candidates for therapeutic interventionsIdentification of Potent and Long-Acting Single-Chain Peptide .... Their involvement in tissue remodeling, vasodilation, and anti-inflammatory processes suggests potential applications in treating conditions ranging from fibrotic diseases and cardiovascular disorders to reproductive health issues. The development of recombinant human relaxin peptides, such as Relaxin-2 Peptide ≥98% (HPLC), human recombinant, has facilitated their use in research and clinical studies. While challenges remain in optimizing their delivery and efficacy, ongoing research into their structure-activity relationships and signaling pathways continues to unlock their full therapeutic potential. The ability to synthesize these complex peptides, as demonstrated by early efforts in total synthesis, has been a significant advancement in making them available for broader scientific and medical exploration.
Join the newsletter to receive news, updates, new products and freebies in your inbox.